WRKY18 Antibody

What is WRKY18 and why is it significant in plant research?

WRKY18 is a pathogen-induced transcription factor that binds to W-box sequences in vitro and plays crucial roles in plant immune responses. It belongs to the WRKY transcription factor family, which is involved in diverse biotic and abiotic stress responses as well as developmental processes in plants . WRKY18 (gene ID: AT4G31800) forms protein complexes with WRKY40 and WRKY60 and has partially redundant yet distinct roles in plant defense against pathogens, with WRKY18 often playing a more significant role than its counterparts . The importance of WRKY18 stems from its central position in transcriptional networks that regulate immune responses, particularly against hemibiotrophic bacterial pathogens like Pseudomonas syringae and necrotrophic fungal pathogens such as Botrytis cinerea .

How should WRKY18 antibody be stored and handled to maintain optimal activity?

For optimal performance and longevity of WRKY18 antibody, proper storage and handling are essential. The antibody should be stored in a manual defrost freezer at -20°C to -70°C, and repeated freeze-thaw cycles should be strictly avoided as they can significantly compromise antibody functionality . Upon receipt, the antibody should be immediately stored at the recommended temperature. If the antibody has been reconstituted, it remains stable for approximately 6 months at -20°C to -70°C under sterile conditions, or 1 month at 2°C to 8°C under sterile conditions . When working with the antibody, aliquoting into smaller volumes after reconstitution is advisable to minimize freeze-thaw cycles and extend usability for long-term research projects.

What are the recognized species cross-reactivities for commercially available WRKY18 antibodies?

The specificity and cross-reactivity of WRKY18 antibodies vary depending on the specific product. Based on the information provided by PhytoAB Inc., their WRKY18 antibody products show different species recognition patterns. The PHY1212A antibody is specific to Arabidopsis thaliana, while the PHY1213A antibody demonstrates broader cross-reactivity, recognizing WRKY18 from Arabidopsis thaliana as well as related proteins in Brassica napus and Brassica rapa . This cross-reactivity information is crucial when designing experiments involving different plant species, particularly for comparative studies across Brassicaceae family members. Researchers should carefully select the appropriate antibody variant based on their experimental plant system to ensure valid and reproducible results.

How can I optimize immunoprecipitation protocols using WRKY18 antibody for protein complex studies?

Optimizing immunoprecipitation (IP) protocols for WRKY18 protein complex studies requires several methodological considerations. First, use fresh plant tissue harvested under the specific stress conditions of interest, as WRKY18 expression and complex formation are condition-dependent . Based on published protocols, prepare protein extracts in a buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 5 mM EDTA, 0.1% Triton X-100, 0.2% Nonidet P-40, and protease inhibitor cocktail. Pre-clear lysates with protein A/G agarose beads before adding the WRKY18 antibody (2-5 μg per mg of total protein) .

For detecting WRKY18 interactions with WRKY40 and WRKY60, crosslinking with 1% formaldehyde prior to extraction can help preserve transient interactions. Incubate the antibody-lysate mixture overnight at 4°C with gentle rotation, followed by addition of protein A/G beads for 2-3 hours. Perform at least 4-5 stringent washes with decreasing salt concentrations to remove non-specific interactions . For verification of results, implement appropriate controls including pre-immune serum and IP in wrky18 knockout lines to confirm specificity. This approach has successfully revealed that WRKY18 forms both homocomplexes and heterocomplexes through Leu zipper motifs, with different functional consequences for DNA binding ability .

What techniques can be used to study WRKY18 binding to W-box sequences in promoter regions?

Several complementary techniques can be employed to study WRKY18 binding to W-box sequences in promoter regions. Chromatin immunoprecipitation followed by sequencing (ChIP-seq) using WRKY18 antibody is the gold standard for genome-wide identification of in vivo binding sites . For this approach, crosslink plant tissue with 1% formaldehyde, isolate and fragment chromatin (200-500 bp fragments), and immunoprecipitate with WRKY18 antibody. The anti-all-WRKY antibody has been validated for ChIP-seq studies and successfully used to identify WRKY18 binding sites .

For in vitro validation, electrophoretic mobility shift assays (EMSAs) can confirm direct binding of recombinant WRKY18 protein to W-box sequences (TTGACC/T). Competition assays with mutated W-box sequences can verify binding specificity . For functional validation of binding sites, reporter gene assays using promoter constructs with wild-type or mutated W-box elements transfected into protoplasts can demonstrate the regulatory impact of WRKY18 binding. Importantly, consider that WRKY18 binding properties can be altered through interactions with other WRKY proteins; for example, WRKY60-18 interaction increases the DNA binding ability of WRKY18, while WRKY60-40 interaction decreases the DNA binding ability of WRKY40 .

How can I effectively use WRKY18 antibody in immunolocalization studies?

For effective immunolocalization of WRKY18 in plant tissues, begin with proper fixation using 4% paraformaldehyde in PBS for 2 hours at room temperature. After embedding in paraffin or preparing cryosections (10-15 μm thick), perform antigen retrieval using citrate buffer (pH 6.0) at 95°C for 10 minutes to expose WRKY18 epitopes that may be masked during fixation .

For immunostaining, block non-specific binding sites with 5% BSA and 0.3% Triton X-100 in PBS for 1 hour at room temperature. Dilute the WRKY18 antibody to an optimized concentration (typically 1:100 to 1:500) in blocking buffer and incubate sections overnight at 4°C in a humidified chamber. After washing with PBS containing 0.1% Tween-20, apply fluorescently-labeled secondary antibodies (1:200 to 1:500) for 1-2 hours at room temperature .

For specificity controls, include parallel processing of tissue from wrky18 knockout plants and pre-immune serum controls. Counterstain nuclei with DAPI (1 μg/ml) for 10 minutes before mounting. This methodology allows for visualization of WRKY18 nuclear translocation upon pathogen challenge or stress treatment, providing valuable insights into the spatio-temporal dynamics of WRKY18 function during plant immune responses .

How can I differentiate between WRKY18 and other closely related WRKY proteins in my experiments?

Differentiating between WRKY18 and closely related WRKY proteins requires a multi-faceted approach. First, assess antibody specificity through western blot analysis using recombinant WRKY proteins and protein extracts from wild-type, wrky18 knockout, and wrky40/60 knockout plants. The expected molecular weight of WRKY18 is approximately 37 kDa, which may differ slightly from WRKY40 (40 kDa) and WRKY60 (60 kDa) .

For more definitive differentiation, implement immunoprecipitation followed by mass spectrometry (IP-MS) to identify the specific WRKY proteins captured by the antibody. This approach has been successfully used to distinguish between 26 different WRKY proteins in Arabidopsis . Additionally, when analyzing ChIP-seq data, distinctive binding patterns can help distinguish WRKY18-specific targets from those of other WRKYs. WRKY18 preferentially binds to W-box elements in promoters of defense-related genes, while its binding profile differs from WRKY40 and WRKY60 despite some overlap .

In cases where antibody cross-reactivity cannot be eliminated, complement antibody-based approaches with transcript-specific methods like RT-qPCR using primers that target unique regions of WRKY18 mRNA. This combined approach provides the most reliable differentiation between WRKY18 and other closely related WRKY family members.

What could cause inconsistent WRKY18 antibody detection in western blot analyses?

Inconsistent WRKY18 detection in western blots can stem from several technical and biological factors. From a technical perspective, WRKY18 protein degradation during extraction is a common issue, as plant tissues contain abundant proteases. Ensure your extraction buffer contains a comprehensive protease inhibitor cocktail and maintain cold temperatures throughout sample processing . Additionally, proper denaturation is crucial—inadequate SDS-PAGE sample preparation can lead to protein aggregation and poor transfer, so ensure complete denaturation at 95°C for 5 minutes in sample buffer containing fresh DTT or β-mercaptoethanol.

From a biological standpoint, WRKY18 expression is highly condition-dependent and can vary significantly based on pathogen exposure, developmental stage, and environmental factors . For consistent detection, standardize plant growth conditions and treatment timing. Most importantly, WRKY18 is rapidly induced upon pathogen challenge—levels can increase substantially within 2 hours of treatment . Therefore, time course experiments are essential to capture peak expression.

Antibody-related issues can also contribute to inconsistency. Over time, repeated freeze-thaw cycles can reduce antibody activity . Use freshly prepared antibody dilutions and optimize blocking conditions to reduce background. If specific bands appear weak, consider using enhanced chemiluminescence substrates with longer exposure times, or signal amplification techniques such as biotin-streptavidin systems.

How should I interpret contradictory results between WRKY18 protein levels and gene expression data?

Contradictory patterns between WRKY18 protein levels and gene expression data are not uncommon and can provide valuable insights into regulatory mechanisms. Several biological explanations may account for such discrepancies. First, post-transcriptional regulation through miRNAs or RNA-binding proteins may affect mRNA stability or translation efficiency, resulting in transcript levels that don't correlate directly with protein abundance . Second, post-translational modifications or protein-protein interactions can significantly impact WRKY18 protein stability and half-life without affecting transcript levels. For instance, interaction with WRKY40 or WRKY60 might stabilize or destabilize WRKY18 protein .

Methodologically, use time-course experiments to track both transcript and protein levels, as temporal delays between transcription and translation can create apparent contradictions at single time points. Comparing protein abundance measured by western blot with transcript levels by RT-qPCR across multiple time points after pathogen challenge or stress treatment can reveal these temporal dynamics .

For comprehensive analysis, combine these approaches with protein stability assays using cycloheximide chase experiments to determine WRKY18 protein half-life under different conditions. This integrated approach has revealed that while some WRKY genes show high transcript levels (e.g., WRKY15, WRKY17), their proteins may not be detected, possibly due to rapid turnover or levels below detection threshold .

How can WRKY18 antibody be used to investigate the WRKY18-40-60 regulatory cluster in stress response pathways?

The WRKY18-40-60 regulatory cluster represents a sophisticated control module in plant stress responses, and WRKY18 antibody serves as a powerful tool for dissecting this complex network. For comprehensive analysis, implement sequential ChIP (ChIP-reChIP) using WRKY18 antibody followed by WRKY40 or WRKY60 antibodies to identify genomic regions co-bound by these transcription factor pairs . This approach has revealed that while these factors can function redundantly, they also exhibit antagonistic effects in certain stress contexts—WRKY18 and WRKY60 enhance plant sensitivity to salt and osmotic stress, while WRKY40 counteracts this effect .

For biochemical characterization of the protein complexes, use co-immunoprecipitation with WRKY18 antibody followed by western blotting for WRKY40 and WRKY60 under different stress conditions. This methodology has demonstrated that these proteins form both homocomplexes and heterocomplexes through Leu zipper motifs, with distinct functional outcomes . Critically, the WRKY60-18 interaction increases DNA binding ability of WRKY18, while the WRKY60-40 interaction decreases DNA binding ability of WRKY40 .

To elucidate the physiological relevance of these interactions, compare the target gene expression profiles in wild-type, single, double, and triple wrky mutants under different stress conditions using RNA-seq combined with WRKY18 antibody ChIP-seq. This integrative approach has revealed that WRKY18 stimulates SA-signaling and enhances resistance to P. syringae, while its co-expression with WRKY40 or WRKY60 enhances susceptibility , highlighting the context-dependent nature of these regulatory interactions.

What approaches can be used to study post-translational modifications of WRKY18 using the antibody?

Post-translational modifications (PTMs) of WRKY18 represent an important regulatory layer that fine-tunes its function, and several approaches utilizing WRKY18 antibody can illuminate these mechanisms. Begin with immunoprecipitation of WRKY18 from plant tissues exposed to different stimuli, followed by mass spectrometry analysis to identify and map phosphorylation, ubiquitination, SUMOylation, and other PTMs . This approach has revealed that many WRKY factors including WRKY18 interact with 14-3-3 proteins, suggesting phosphorylation-dependent regulation .

For phosphorylation-specific studies, use Phos-tag SDS-PAGE followed by western blotting with WRKY18 antibody to visualize mobility shifts caused by phosphorylation events. Complement this with in vitro kinase assays using recombinant WRKY18 and candidate kinases such as MPK3/6, which are known to phosphorylate WRKY transcription factors during immune responses .

To investigate ubiquitination and protein stability, perform cycloheximide chase assays in the presence or absence of proteasome inhibitors (e.g., MG132), followed by western blotting with WRKY18 antibody to monitor protein degradation kinetics. For functional validation of specific PTM sites, generate site-directed mutants of WRKY18 (e.g., phospho-mimetic or phospho-dead variants) and assess their DNA binding properties using EMSAs and their transcriptional activity using reporter gene assays . This comprehensive approach can elucidate how PTMs modulate WRKY18 function in response to different environmental and pathogen challenges.

How can ChIP-seq with WRKY18 antibody be used to construct comprehensive transcriptional networks in plant immunity?

Constructing comprehensive transcriptional networks in plant immunity using WRKY18 antibody ChIP-seq requires an integrated multi-omics strategy. Begin with ChIP-seq experiments across multiple time points after pathogen challenge or immune elicitor treatment (e.g., flg22) to capture the dynamic binding profile of WRKY18 . The anti-all-WRKY antibody has proven effective for ChIP-seq studies, successfully identifying binding sites for numerous WRKY proteins including WRKY18 .

Integrate ChIP-seq data with RNA-seq from wild-type and wrky18 mutant plants under identical conditions to distinguish between direct and indirect transcriptional effects. This approach has revealed that WRKY18 and WRKY40 function partly redundantly but regulate highly diverse sets of genes . For network construction, analyze enriched DNA motifs within WRKY18-bound regions, focusing on the canonical W-box (TTGACC/T) and potential co-occurring motifs that might indicate combinatorial regulation with other transcription factors .

To understand hierarchical relationships within the network, perform time-resolved ChIP-seq and RNA-seq experiments, which have demonstrated that constitutively expressed WRKYs often act as repressors of flg22-induced WRKY genes and are replaced by induced WRKYs after stimulation . Further extend the network by incorporating protein-protein interaction data from co-immunoprecipitation experiments with WRKY18 antibody followed by mass spectrometry. This comprehensive approach has identified 26 different WRKY proteins in non-treated seedlings and revealed significant changes in WRKY protein complexes after immune elicitation , providing crucial insights into the dynamic rewiring of transcriptional networks during immune responses.

How can WRKY18 antibody be used to study the role of WRKY18 in metabolic pathway regulation?

WRKY18 antibody offers valuable approaches for investigating the increasingly recognized role of WRKY transcription factors in regulating specialized metabolic pathways in plants. Implement ChIP-seq with WRKY18 antibody followed by integration with metabolomic data to identify metabolic genes directly regulated by WRKY18 . This approach has revealed that WRKY transcription factors can regulate secondary metabolite biosynthesis, which plays crucial roles in plant defense responses.

For functional validation, compare metabolite profiles between wild-type and wrky18 mutant plants under control and stress conditions using LC-MS/MS or GC-MS. Focus particularly on defense-related compounds such as phytoalexins, glucosinolates (in Brassicaceae), and phenylpropanoids, as WRKY factors have been implicated in their regulation . For instance, some WRKY transcription factors have been shown to up-regulate genes involved in triterpene biosynthesis, and HbWRKY1 has been associated with increased biosynthesis of natural rubber in Hevea brasiliensis .

To dissect the molecular mechanisms, perform transactivation assays using promoter regions of key metabolic genes fused to reporter constructs in protoplasts expressing WRKY18. This can determine whether WRKY18 directly activates or represses these pathways. Additionally, use the WRKY18 antibody in protein complex purification followed by mass spectrometry to identify metabolic enzymes that might be directly regulated through protein-protein interactions rather than transcriptional control. This multi-faceted approach will provide comprehensive insights into how WRKY18 coordinates metabolic reprogramming during plant defense responses.

What strategies can help differentiate between the roles of WRKY18 in biotic versus abiotic stress responses?

Differentiating the roles of WRKY18 in biotic versus abiotic stress responses requires carefully designed comparative experiments using WRKY18 antibody. First, conduct parallel ChIP-seq experiments with WRKY18 antibody under distinct biotic stresses (e.g., bacterial or fungal infection) and abiotic stresses (e.g., drought, salt, cold) to identify stress-specific and shared binding targets . This approach has revealed that while WRKY18 participates in both stress types, its regulatory networks differ substantially between them.

For protein-level regulation, compare WRKY18 abundance, subcellular localization, and post-translational modifications across stress types using western blotting, immunolocalization, and IP-MS with WRKY18 antibody. This has shown that WRKY18 stimulates SA-signaling pathways during biotic stress, while during abiotic stress, WRKY18 and WRKY60 enhance plant sensitivity to salt and osmotic stress .

To dissect the functional specificity, analyze protein interaction partners of WRKY18 under different stress conditions using co-immunoprecipitation with WRKY18 antibody followed by mass spectrometry. This strategy has revealed stress-specific interaction networks—during pathogen infection, WRKY18 interactions focus on immune signaling components, while under abiotic stress, interactions with factors involved in ABA signaling predominate .

For mechanistic validation, perform comparative transcriptome analyses in wild-type and wrky18 mutant plants under both stress types, coupled with WRKY18 ChIP-seq data integration. This comprehensive approach has demonstrated that WRKY18 has a positive role in effector-triggered resistance towards avirulent Pseudomonas syringae DC3000 expressing the AvrRPS4 effector gene, a response highly specific to this particular pathogen interaction .

How can researchers use WRKY18 antibody to investigate evolutionary conservation of WRKY-mediated immune responses across plant species?

Investigating evolutionary conservation of WRKY-mediated immune responses across plant species using WRKY18 antibody requires a comparative immunological approach. Begin by assessing cross-reactivity of the WRKY18 antibody against protein extracts from diverse plant species using western blotting. The PHY1213A antibody variant recognizes WRKY18 not only in Arabidopsis thaliana but also in Brassica napus and Brassica rapa , providing a starting point for comparative studies within Brassicaceae.

For broader evolutionary studies, implement immunoprecipitation with WRKY18 antibody followed by mass spectrometry across multiple plant species to identify orthologous WRKY proteins and their interaction networks. Compare binding specificities through ChIP experiments followed by DNA motif analysis to determine whether the W-box recognition is conserved across species. While the WRKY DNA-binding domain is mostly conserved, variations exist—for example, NtWRKY12 has the sequence WRKYGKK instead of WRKYGQK and binds specifically to the WK box (TTTTCCAC) rather than the canonical W-box .

For functional conservation analysis, perform complementation experiments by expressing WRKY18 orthologs from different species in Arabidopsis wrky18 mutants, followed by immunoprecipitation with WRKY18 antibody to assess their incorporation into native protein complexes and ChIP-seq to determine their binding profiles. This approach can reveal whether orthologous WRKY proteins can functionally substitute for Arabidopsis WRKY18 in immune responses.

Additionally, compare PTM patterns of WRKY18 orthologs across species by immunoprecipitation and mass spectrometry to determine whether regulatory mechanisms are conserved. This comprehensive evolutionary analysis can provide insights into the core conserved functions of WRKY transcription factors in plant immunity versus species-specific adaptations to particular pathogen pressures.

How might WRKY18 antibody contribute to understanding WRKY18's role in emerging plant stress adaptation mechanisms?

WRKY18 antibody will be instrumental in elucidating emerging aspects of plant stress adaptation mechanisms through several innovative research directions. As climate change introduces novel combinations of biotic and abiotic stresses, use WRKY18 antibody in ChIP-seq experiments under multiple stress conditions to map how WRKY18 binding patterns change during simultaneous exposure to pathogen infection and drought or heat stress . This will reveal how transcriptional networks reconfigure under complex stress scenarios.

Apply WRKY18 antibody in proximity-labeling approaches such as BioID or APEX2 fused to WRKY18 to identify transient interaction partners under emerging stress conditions. This technique will capture dynamic reorganization of protein complexes that may not be detected by traditional co-immunoprecipitation. Additionally, implement single-cell approaches using WRKY18 antibody for immunohistochemistry combined with single-cell RNA-seq to understand cell-type-specific responses, as stress adaptation often involves tissue-specific transcriptional reprogramming .

For translational applications, use WRKY18 antibody to screen for chemical compounds that modulate WRKY18 binding to DNA or protein partners, potentially identifying molecules that could prime plant defense responses. Furthermore, combine WRKY18 antibody ChIP-seq with chromosome conformation capture techniques (Hi-C) to understand how three-dimensional chromatin organization influences WRKY18-mediated gene regulation during stress adaptation . These approaches will provide unprecedented insights into how WRKY18 coordinates complex adaptive responses to emerging environmental challenges.

What methodological advances might enhance the utility of WRKY18 antibody in plant immunity research?

Methodological innovations promise to significantly enhance WRKY18 antibody applications in plant immunity research. Development of phospho-specific WRKY18 antibodies would enable direct monitoring of WRKY18 activation states during immune responses, as phosphorylation is a key regulatory mechanism for WRKY transcription factors . Additionally, creating conformation-specific antibodies that distinguish between DNA-bound and unbound WRKY18 would provide real-time insights into its regulatory activity.

Adapting WRKY18 antibody for CUT&RUN or CUT&Tag technologies would enhance the sensitivity and resolution of chromatin binding studies with minimal input material, allowing for cell-type-specific or even single-cell profiling of WRKY18 binding sites during immune responses . For live-cell imaging, developing fluorescent nanobodies derived from WRKY18 antibody would enable real-time visualization of WRKY18 dynamics during pathogen challenge without the need for genetic modification of the plant.

Implementing WRKY18 antibody in spatial transcriptomics and proteomics approaches would reveal tissue-specific regulatory networks controlled by WRKY18 during local and systemic acquired resistance. Furthermore, adapting the antibody for IP-MS experiments with cross-linking mass spectrometry (XL-MS) would provide structural insights into WRKY18-containing protein complexes and how they reorganize during immune responses .

For high-throughput applications, developing WRKY18 antibody-based biosensors that report on WRKY18 activation states would facilitate large-scale chemical or genetic screens for modulators of plant immunity. These methodological advances would collectively transform our ability to dissect the complex regulatory functions of WRKY18 in plant immune responses with unprecedented temporal and spatial resolution.

How can integrating WRKY18 antibody-based approaches with emerging technologies advance our understanding of plant transcriptional networks?

Integrating WRKY18 antibody-based approaches with cutting-edge technologies will revolutionize our understanding of plant transcriptional networks. Combining WRKY18 ChIP-seq with ATAC-seq or DNase-seq would provide comprehensive maps of how chromatin accessibility changes coincide with WRKY18 binding during immune responses . This integration would reveal whether WRKY18 functions as a pioneer factor that can access closed chromatin or depends on other factors to expose its binding sites.

Implementing WRKY18 antibody in CRISPRi/CRISPRa screens would enable systematic functional interrogation of WRKY18 binding sites identified through ChIP-seq, determining which sites are necessary and sufficient for specific immune responses. Furthermore, integrating WRKY18 ChIP-seq data with multi-omics approaches including proteomics, metabolomics, and phenomics would establish causal relationships between WRKY18-regulated transcriptional networks and downstream physiological outcomes .

Applying machine learning and network inference algorithms to integrated datasets generated using WRKY18 antibody would predict emergent properties of WRKY-regulated networks and generate testable hypotheses about network resilience and vulnerability. Additionally, combining WRKY18 antibody approaches with organ-on-chip or plant-on-chip technologies would enable real-time monitoring of WRKY18 dynamics in response to precisely controlled immune elicitors or pathogen treatments.